Patents by Inventor Kathleen Keegan

Kathleen Keegan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180087079
    Abstract: Methods of modulating the properties of a cell culture expressing a protein of interest are provided. In various embodiments the methods relate to the addition of cell cycle inhibitors to growing cell cultures.
    Type: Application
    Filed: November 30, 2017
    Publication date: March 29, 2018
    Applicant: AMGEN INC.
    Inventors: Zhimei DU, John Douglas MCCARTER, Pranhitha REDDY, Andrew William SNOWDEN, Lawrence R. MCGEE, John Gordon ALLEN, David Lawrence TREIBER, Kathleen KEEGAN, Zhihong LI
  • Publication number: 20150353542
    Abstract: Methods of modulating the properties of a cell culture expressing a protein of interest are provided. In various embodiments the methods relate to the addition of cell cycle inhibitors to growing cell cultures.
    Type: Application
    Filed: December 11, 2013
    Publication date: December 10, 2015
    Applicant: AMGEN INC.
    Inventors: Zhimei DU, John Douglas MCCARTER, Pranhitha REDDY, Andrew William SNOWDEN, Lawrence R. MCGEE, John Gordon ALLEN, David Lawrence TREIBER, Kathleen KEEGAN, Zhihong LI
  • Publication number: 20140199728
    Abstract: Methods of modulating the properties of a cell culture expressing a protein of interest are provided. In various embodiments the methods relate to the addition of cell cycle inhibitors to growing cell cultures.
    Type: Application
    Filed: December 11, 2013
    Publication date: July 17, 2014
    Applicant: AMGEN INC.
    Inventors: Zhimei DU, John Douglas McCARTER, Pranhitha REDDY, Andrew William SNOWDEN, Lawrence R. MCGEE, John Gordon ALLEN, David Lawrence TREIBER, Kathleen KEEGAN, Zhihong LI
  • Publication number: 20050245525
    Abstract: Aryl- and heteroaryl-substituted urea compounds useful in the treatment of diseases and conditions related to DNA damage or lesions in DNA replication are disclosed. Methods of making the compounds, and their use as therapeutic agents, for example, in treating cancer and other diseases characterized by defects in DNA replication, chromosome segregation, or cell division also are disclosed.
    Type: Application
    Filed: April 27, 2005
    Publication date: November 3, 2005
    Applicant: ICOS CORPORATION
    Inventors: Kathleen Keegan, Edward Kesicki, John Gaudino, Adam Cook, Scott Cowen, Laurence Burgess
  • Publication number: 20050112643
    Abstract: Polynucleotides encoding novel Atr-2 cell cycle checkpoint polypeptides are disclosed, along with expression constructs comprising the polynucleotides, host cells transformed with the expression constructs, methods to make the Atr-2 polypeptides using the host cells, Atr-2 polypeptides, and binding partners of the Atr-2 polypeptides.
    Type: Application
    Filed: September 30, 2004
    Publication date: May 26, 2005
    Inventors: Kate Loughney, Kathleen Keegan